Delaying Bone Drugs After Cancer Spreads to Bone Nearly Doubles Fracture Risk, Study Finds
A retrospective landmark and propensity score–matched analysis found that delaying bone-modifying agent therapy beyond six months after a bone metastasis ...
Tag: denosumab
Jawbone Necrosis Affects One in Eight Breast Cancer Patients on Bone Drugs, Finnish Registry Finds
A nationwide Finnish registry study of 652 breast cancer patients with bone metastases found jawbone necrosis in 12.6 percent of ...
Parkinson’s Doubles Hip Fracture Risk, Yet Osteoporosis Drugs Are No More Likely After Breaks
A nationwide Finnish cohort study found that people with Parkinson's disease receive anti-osteoporosis medications at rates similar to or higher ...
Bone-Protecting Drug Combination Boosts Radiotherapy Against Lung Cancer Spread to Bone
A new translational study shows that adding RANKL inhibition to lutetium-177-labeled bisphosphonate radioligand therapy stabilizes the bone microenvironment and sharply ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!